Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
We break down expense ratios across popular index funds and show how choosing the lowest-cost options can improve long-term retirement outcomes.
28,023 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
A mid-sized industrial company delivered a dramatic rally, with Powell Industries stock surges pushing shares up dram...
Top U.S. homebuilders are backing Avila Real Estate Capital’s AREC Fund II, signaling a shift in housing finance as b...
A biotech stock has surged 355%, catching the eye of every investor from day traders to pension funds. A prominent he...
A high-profile trust dispute highlights how beneficiaries may access funds during legal battles. This guide explains ...
The SEC approves WisdomTree's request for exemptive relief, unlocking 24/7 trading and near-instant settlement for to...
Three sector ETFs are beating the Nasdaq tech index in 2026, signaling a shift toward defense tech, electrification, ...
When a marquee performer vanishes from WWE TV, questions multiply about money and plans. This article uses that scena...
A decade after her last album, Rihanna overtakes Taylor Swift in Spotify listenership, revealing lessons about catalo...
PayPal faces a tough stretch in the public eye, yet cash flow and a disciplined capital plan hint at upside. Here’s w...
A stock that falls 30% in 2026 isn’t automatically a loss. This guide shows how to evaluate a growth stock down 2026,...